CBD had no overall effect on brain neurometabolites in people with alcohol use disorder, but specifically normalized glutathione, glutamate, and GABA levels in participants who had consumed alcohol the day before.
Addiction researchers, neurochemists, and clinicians exploring novel AUD treatments.
CBD normalized three key brain chemicals specifically after alcohol exposure, with no effect during abstinence
What the researchers found
In 22 participants with AUD receiving 800 mg CBD or placebo in a crossover trial, no overall treatment effects on neurometabolites were found. However, CBD sessions showed significantly higher glutathione (p<0.001), glutamate/glutamine (p=0.001), and GABA (p=0.002) concentrations specifically for participants who had consumed alcohol the previous day, with no effect in abstinent participants.
Why it matters
Alcohol disrupts brain neurochemistry, and finding that CBD selectively normalizes these disruptions after drinking sessions could position CBD as an adjunct treatment for alcohol use disorder.
The numbers in context
22 participants, 800 mg CBD per day, crossover design. GSH (p<0.001), GLx (p=0.001), and GABA (p=0.002) all significantly higher during CBD sessions for participants who drank the previous day. No effects in abstinent participants.
How the study worked
Crossover double-blind randomized trial with 22 non-treatment-seeking AUD participants receiving 800 mg CBD or matched placebo. Neurometabolites measured in the dorsal anterior cingulate cortex using proton magnetic resonance spectroscopy (1H-MRS).
What this study cannot tell us
Very small sample (n=22). Non-treatment-seeking participants may not represent clinical AUD patients. Post hoc subgroup analysis by recent alcohol use was exploratory. Single dose level tested. Short treatment duration.
How to read the evidence
Double-blind crossover RCT design is strong, but very small sample and post hoc subgroup analysis reduce confidence in the specific findings.
When this study was published
2025 publication.
The bigger picture
The context-dependent nature of CBD effects (only working after alcohol exposure) aligns with preclinical evidence that CBD is neuroprotective specifically against alcohol-induced damage rather than broadly altering brain chemistry.
Questions still open
- Would longer CBD treatment show cumulative neurometabolite effects?
- Could CBD maintain these neurometabolite normalizations in treatment-seeking AUD patients?
Read the original research
The effect of cannabidiol on neurometabolite levels in alcohol use disorder.
Alcohol and alcoholism (Oxford, Oxfordshire), 60(4)
Citation
Hurzeler, Tristan; DeMayo, Marelyna; Logge, Warren; Watt, Joshua; McGregor, Iain S; Suraev, Anastasia; Haber, Paul; Morley, Kirsten. (2025). The effect of cannabidiol on neurometabolite levels in alcohol use disorder.. Alcohol and alcoholism (Oxford, Oxfordshire), 60(4). https://doi.org/10.1093/alcalc/agaf029
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk